4.1 Article

Current practice in diagnostic genetic testing of the epilepsies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Genetic testing for the epilepsies: A systematic review

Beth R. Sheidley et al.

Summary: This study reviewed the diagnostic yield of genetic tests commonly used for patients with epilepsy, and found that genome sequencing had the highest yield. It also highlighted the importance of assessing the clinical and personal utility of genetic testing for epilepsy patients and standardizing patient characteristics reporting.

EPILEPSIA (2022)

Article Biochemistry & Molecular Biology

Exome first approach to reduce diagnostic costs and time - retrospective analysis of 111 individuals with rare neurodevelopmental disorders

Julia Klau et al.

Summary: This study aimed to investigate the time, diagnostic procedure, and cost saving potential of early exome sequencing in a cohort of individuals with neurodevelopmental disorders. The results showed that exome sequencing primarily saved costs in genetic, metabolic, and cranial magnetic resonance imaging examinations in this German cohort.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Article Genetics & Heredity

Familial adult myoclonic epilepsy (FAME): clinical features, molecular characteristics, pathophysiological aspects and diagnostic work-up

Lorenz Peters et al.

Summary: Familial adult myoclonic epilepsy is a rare genetic disorder characterized by myoclonus and seizures. The disorder is caused by a repeat expansion in introns of six different genes, and the exact pathophysiological mechanisms are still unknown.

MEDIZINISCHE GENETIK (2022)

Article Clinical Neurology

L-Serine Treatment is Associated with Improvements in Behavior, EEG, and Seizure Frequency in Individuals with GRIN-Related Disorders Due to Null Variants

Ilona Krey et al.

Summary: This study provides evidence that L-serine treatment may improve clinical outcomes in GRIN-related disorders caused by loss-of-function missense variants or null variants.

NEUROTHERAPEUTICS (2022)

Article Medicine, Research & Experimental

High-throughput evaluation of epilepsy-associated KCNQ2 variants reveals functional and pharmacological heterogeneity

Carlos G. Vanoye et al.

Summary: This study investigated the functional and pharmacological properties of numerous KCNQ2 gene variants using automated patch clamp recordings. The results showed that most disease-associated KCNQ2 variants exhibited prominent loss-of-function with dominant-negative effects, providing strong evidence for their pathogenicity. Additionally, the response of KCNQ2 variants to retigabine, a proposed precision therapy, varied depending on the genotype.

JCI INSIGHT (2022)

Article Clinical Neurology

Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study

Kristina Ibanez et al.

Summary: Background repeat expansion disorders caused by short tandem DNA repeats are clinically heterogeneous and difficult to diagnose. A study found that whole genome sequencing shows high accuracy in detecting neurological repeat expansion disorders.

LANCET NEUROLOGY (2022)

Article Clinical Neurology

Nicotine: A Targeted Therapy for Epilepsy Due to nAChR Gene Variants

Jordana Fox et al.

Summary: Nicotine patches have shown to be effective in reducing seizures in patients with genetic variants of the neuronal nicotinic acetylcholine receptor gene. This targeted therapy could be a potential experimental treatment for medically intractable epilepsy, but further clinical trials are needed to fully understand the therapeutic effects.

JOURNAL OF CHILD NEUROLOGY (2021)

Article Clinical Neurology

Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter

Andreea Nissenkorn et al.

Summary: This study described a patient with a KCNQ2 gene mutation and implemented personalized treatment using electrophysiological analysis. The results showed that retigabine may be used for precision therapy in patients with KCNQ2-related epilepsy due to loss-of-function variants, and withdrawal of retigabine, due to revocation of marketing authorization, caused an increase in seizure burden.

EPILEPTIC DISORDERS (2021)

Article Pharmacology & Pharmacy

Imprecision in Precision Medicine: Differential Response of a Disease-Linked GluN2A Mutant to NMDA Channel Blockers

Jenna R. Gale et al.

Summary: NMDA antagonist memantine effectively blocks dendrotoxicity mediated by GluN2A-P552R, while ketamine does not. The differences between these drugs in treating GRIN2A-mediated neurological disorders suggest that not all NMDA antagonists may have equal clinical utility despite a shared mechanism of action.

FRONTIERS IN PHARMACOLOGY (2021)

Article Clinical Neurology

Modeling seizures in the Human Phenotype Ontology according to contemporary ILAE concepts makes big phenotypic data tractable

David Lewis-Smith et al.

Summary: A redesigned HPO seizure subontology based on ILAE classification was created, increasing the number of descriptive concepts and annotations for seizures. This enhancement led to a significant increase in the amount of information about individuals' seizures, particularly improving the relationship between different seizure types.

EPILEPSIA (2021)

Review Genetics & Heredity

Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution

Zornitza Stark et al.

Summary: A systematic comparison of 80 virtual gene panels used by multiple diagnostic providers in the UK and Australia was conducted, resulting in the identification and review of 2,144 discordant gene ratings using the shared curation platform PanelApp. This study highlights the utility of sharing structured gene-disease validity assessments and collaborative discordance resolution in establishing national and international consensus.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Article Genetics & Heredity

GenomeDiver: a platform for phenotype-guided medical genomic diagnosis

Nathaniel M. Pearson et al.

Summary: GenomeDiver facilitates collaboration between clinicians and diagnostic laboratories by utilizing HPO terms to enrich structured phenotype data, ultimately improving the outcome of genomic diagnostic testing.

GENETICS IN MEDICINE (2021)

Article Cell Biology

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy

Ulrike B. S. Hedrich et al.

Summary: Developmental and epileptic encephalopathies are severe disorders characterized by epilepsy, intellectual disability, and other neuropsychiatric symptoms with limited treatment options. Through a precision medicine approach, it was found that the K+ channel blocker 4-aminopyridine could effectively alleviate symptoms in patients with KCNA2-encephalopathy caused by variants in the K(V)1.2 subunit. Results from n-of-1 trials showed that most patients benefited from the treatment with 4-aminopyridine, with well-tolerated dosages up to 2.6 mg/kg per day.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Clinical Neurology

Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies

Elizabeth E. Palmer et al.

Summary: Developmental and epileptic encephalopathies (DEEs) are severe epileptic disorders that typically start in early childhood and can result in drug-resistant seizures, developmental delays, and cognitive impairments. Targeted therapies for specific genetic DEE phenotypes are needed to improve health outcomes. Understanding the natural history of the disorder is crucial for assessing treatment efficacy and designing clinical trials.

NEUROTHERAPEUTICS (2021)

Article Clinical Neurology

Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies

Elizabeth Emma Palmer et al.

Summary: In the study, whole genome sequencing (WGS) improved diagnostic yield over exome sequencing (ES) primarily through the detection of complex structural variants, and most diagnoses in patients were related to genes not included in the multigene panel (MGP). Additionally, autosomal recessive or X-chromosome linked diagnoses accounted for 42% of the total cases, highlighting the importance of further research in assessing the pathogenicity of novel variants in neurogenetic disorders such as DEE.

NEUROLOGY (2021)

Article Clinical Neurology

Developmental and epileptic encephalopathy: Personal utility of a genetic diagnosis for families

Jennifer S. Jeffrey et al.

Summary: Receiving a genetic diagnosis can improve families' understanding of the trajectory of DEE, increase hope for the future, and facilitate communication with others. Having an answer for the cause of their child's DEE alleviates parental guilt and self-blame, aiding families in processing grief and moving forward. Delay in receiving a genetic diagnosis may diminish its psychological impact.

EPILEPSIA OPEN (2021)

Article Clinical Neurology

Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain

Zimeng Ye et al.

Summary: Brain somatic mutations are increasingly recognized as a cause of various neurological disorders, and liquid biopsy of cerebrospinal fluid has been found to be valuable in detecting somatic mosaicism in non-malignant brain diseases. The study demonstrates that cell-free DNA in cerebrospinal fluid is brain-derived and may aid in investigating mosaic neurological disorders where brain tissue is unavailable.

BRAIN COMMUNICATIONS (2021)

Article Genetics & Heredity

De-novo mutations in patients with chronic ultra-refractory epilepsy with onset after age five years

Mark McCormack et al.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2020)

Article Biochemistry & Molecular Biology

Recommendations for designing genetic test reports to be understood by patients and non-specialists

George D. Farmer et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Review Genetics & Heredity

New Diagnostic Approaches for Undiagnosed Rare Genetic Diseases

Taila Hartley et al.

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020 (2020)

Article Clinical Neurology

Utility of genetic testing for therapeutic decision-making in adults with epilepsy

Katrine M. Johannesen et al.

EPILEPSIA (2020)

Article Biochemistry & Molecular Biology

A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability

Katherine A. Benson et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Article Genetics & Heredity

Re-evaluating the first-tier status of fragile X testing in neurodevelopmental disorders

Lauren A. Borch et al.

GENETICS IN MEDICINE (2020)

Article Cell Biology

Predicting functional effects of missense variants in voltage-gated sodium and calcium channels

Henrike O. Heyne et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Clinical Neurology

Parental mosaicism in epilepsies due to alleged de novo variants

Rikke S. Moller et al.

EPILEPSIA (2019)

Article Clinical Neurology

Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus

Ivann Sanchez Fernandez et al.

NEUROLOGY (2019)

Article Multidisciplinary Sciences

Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP

Anja Thormann et al.

NATURE COMMUNICATIONS (2019)

Article Genetics & Heredity

Mendelian Gene Discovery: Fast and Furious with No End in Sight

Michael J. Bamshad et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2019)

Editorial Material Genetics & Heredity

PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels

Antonio Rueda Martin et al.

NATURE GENETICS (2019)

Article Biochemistry & Molecular Biology

The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study

Sorina M. Papuc et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2019)

Article Clinical Neurology

Implications of genetic diagnostics in epilepsy surgery candidates: A single-center cohort study

Maurits W. C. B. Sanders et al.

EPILEPSIA OPEN (2019)

Letter Medicine, General & Internal

Parental Mosaicism in De Novo Epileptic Encephalopathies

Candace T. Myers et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Multidisciplinary Sciences

Common genetic variants contribute to risk of rare severe neurodevelopmental disorders

Mari E. K. Niemi et al.

NATURE (2018)

Review Clinical Neurology

Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review

Remi Stevelink et al.

EPILEPTIC DISORDERS (2018)

Article Clinical Neurology

Audit of use of stiripentol in adults with Dravet syndrome

S. Balestrini et al.

ACTA NEUROLOGICA SCANDINAVICA (2017)

Article Clinical Neurology

CAD mutations and uridine-responsive epileptic encephalopathy

Johannes Koch et al.

Article Clinical Neurology

CAD mutations and uridine-responsive epileptic encephalopathy

Johannes Koch et al.

Article Genetics & Heredity

Systematic Phenomics Analysis Deconvolutes Genes Mutated in Intellectual Disability into Biologically Coherent Modules

Korinna Kochinke et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2016)

Article Genetics & Heredity

Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent Epilepsy

Niklas Darin et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2016)

Article Clinical Neurology

Rapid and safe response to low-dose carbamazepine in neonatal epilepsy

Tristan T. Sands et al.

EPILEPSIA (2016)

Article Clinical Neurology

Primer Part 1-The building blocks of epilepsy genetics

Ingo Helbig et al.

EPILEPSIA (2016)

Article Genetics & Heredity

Pitfalls in genetic testing: the story of missed SCN1A mutations

Tania Djemie et al.

MOLECULAR GENETICS & GENOMIC MEDICINE (2016)

Article Genetics & Heredity

Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies

Rikke S. Moller et al.

MOLECULAR SYNDROMOLOGY (2016)

Article Genetics & Heredity

KCNQ2 encephalopathy Features, mutational hot spots, and ezogabine treatment of 11 patients

John J. Millichap et al.

NEUROLOGY-GENETICS (2016)

Article Clinical Neurology

Early and effective treatment of KCNQ2 encephalopathy

Tiziana Pisano et al.

EPILEPSIA (2015)

Review Clinical Neurology

Mitochondrial dysfunction and seizures: the neuronal energy crisis

Gabor Zsurka et al.

LANCET NEUROLOGY (2015)

Article Genetics & Heredity

De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy

Steffen Syrbe et al.

NATURE GENETICS (2015)

Article Clinical Neurology

Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy

Goekce Orhan et al.

ANNALS OF NEUROLOGY (2014)

Article Clinical Neurology

Copy Number Variation Plays an Important Role in Clinical Epilepsy

Heather Olson et al.

ANNALS OF NEUROLOGY (2014)

Article Clinical Neurology

Familial risk of epilepsy: a population-based study

Anna L. Peljto et al.

Article Clinical Neurology

GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine

Tyler Mark Pierson et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)

Article Genetics & Heredity

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Robert C. Green et al.

GENETICS IN MEDICINE (2013)

Article Clinical Neurology

Genetic testing in the epilepsies-Report of the ILAE Genetics Commission

Ruth Ottman et al.

EPILEPSIA (2010)

Review Clinical Neurology

Navigating the channels and beyond: unravelling the genetics of the epilepsies

Ingo Helbig et al.

LANCET NEUROLOGY (2008)